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Background: Control of blood pressure is frequently inadequate in spite of availability of several classes of well
tolerated and effective antihypertensive drugs. Several factors, including the use of suboptimal doses of drugs,
inadequate or ineffective treatments and poor drug compliance may be the reason for this phenomenon. The aim
of the current non- randomized study was to evaluate the effectiveness of a Home-Based Telemedicine service in
patients with uncontrolled hypertension.
Methods: 74 patients were enrolled in a Home Based Telemedicine group and 94 patients in the Usual Care group.
At baseline and at the end of the study, patients in both groups were seen in a cardiology office. Patients in Home
Based Telemedicine group additionally were followed by a physician-nurse, through scheduled and unscheduled
telephone appointments. These patients also received a blood pressure measuring device that could transmit the
readings to a central data monitor via secure data connection.
Results: During the study period (80 ± 25 days), a total of 17401 blood pressure measurements were taken in the
Home Based Telemedicine group corresponding to 236 ± 136 readings per patient and a mean daily measurement
of 3 ± 1.7. The scheduled telephone contacts (initiated by the nurse) equaled to 5.2 ± 4.3/patient (370 in total) and
the unscheduled telephone contacts (initiated by the patients) were 0.4 ± 0.9/patient (30 in total). The mean systolic
blood pressure values decreased from 153 ± 19 mmHg to 130 ± 15 mmHg (p < 0.0001) at the end of the study and
diastolic blood pressure values decreased from 89 ± 10 mmHg to 76 ± 11 mmHg (p < 0.0001). In the Usual Care
group, the mean systolic blood pressure values decreased from 156 ± 16 mmHg to 149 ± 17 mmHg (p < 0.05) at
the end of the study and diastolic blood pressure values decreased from 90 ± 8 mmHg to 86 ± 9 mmHg (p < 0.05).
The changes in drug therapy initiated following telephone contacts were 1.81 ± 1.73 per patient.
Conclusions: The addition of a structured physician-nurse approach supported by remote telemonitoring of blood
pressure is likely to improve outcome in patients with uncontrolled hypertension.
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Many epidemiological studies have shown that the treat-
ment and control of blood pressure (BP) is inadequate
in more than 50% of hypertensive patients in spite of
availability of several classes of well tolerated and effect-
ive antihypertensive drugs [1,2]. Several factors including
the use of suboptimal doses of drugs, inadequate or* Correspondence: palmira.bernocchi@fsm.it
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the reason for this phenomenon [3,4].
The guidelines of the European Society of Cardiology
(ESC)/European Society of Hypertension (ESH) [5] rec-
ommend close collaboration between the general practi-
tioners (GPs) and specialist centers for diagnosing and
treating hypertensive patients. This closer collaboration
results in better stabilization and maintenance of BP
values in the reference range, over time [6-8].ral Ltd. This is an Open Access article distributed under the terms of the Creative
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facilitate the exchange of information and communication
between GPs and specialists, as well as telemonitoring
for the transmission of patient parameters, including BP
[4,9-13]. The available data show that it is possible to
improve BP control in hypertensive patients, either with
or without complications, by changing treatment regi-
mens via a telemedicine approach [4,7].
Systematic reviews have shown that in patients with
hypertension, home blood pressure monitoring compared
to a simple check at GPs offices may play an important role
in improving control of systolic and diastolic BP (SBP and
DBP) and treatment adjustment [9,14-17]. Published papers
increasingly show the central and crucial role of properly
trained nursing staff in coordinating all the health care pro-
fessionals involved in the home management program, in-
cluding providing advice to patients on life style changes,
diet, exercise and smoking habits [18-20].
Reaching and maintaining the target value of blood
pressure, the adherence to therapy, the reporting of the
drug side effects and the change of life-style condition to
reduce cardiovascular risk factors are the gold standard
of our Home-Based Telemedicine (HBT) service.
The aim of the current non randomized “real life”
study was to evaluate the effectiveness of a structured
physician-nurse approach supported by remote BP tele-
monitoring, in patients with uncontrolled hypertension.
The effectiveness was evaluated by assessing changes in
BP values confirmed by ABPM. The data were compared
with those collected in patients being followed in usual
care conditions during the same period.
We also verified the costs of this service to provide
credibility and evidence of its economic viability, so that
this model could be applied to large number of patients
in future studies.Methods
Study design and participants
The study was approved by the Central Ethic Committee of
Fondazione Salvatore Maugeri (Pavia, Italy) and followed
the principles stated in the Declaration of Helsinki.
All patients were consecutively screened between
September 2009 and September 2011 Patients came from
a rural region and were referred to our outpatient clinic
(at Fondazione Maugeri, Lumezzane Medical Center) by
GPs for a cardiologic consultation.
The inclusion criteria were: i) new finding of BP
values >140/90 mmHg or history of 24-h ambulatory BP
monitoring (ABPM) values ≥125/80 according to ESC
guidelines - ESH 2007 [21] or previous diagnosis of
hypertension with evidence of BP values not adequately
controlled by the current therapy; ii) age > 18 year and
iii) having an in-home analog telephone line.We excluded patients residing in long term care facil-
ities, and those with severely cognitive impairments or
those with poor prognosis.
All patients involved in the study were from a rural-
mountain region, where cellular phone connection prob-
lems are quite frequent. Therefore, we first check the
T-Mobile coverage maps of the patient’s zone; then asked
the patient to confirm the availability of telephone cover-
age. For this reason we were obliged to enrol in the HBT
group only patients who could prove to have a good cellu-
lar phone connection in their living area, while patients
without cellular coverage were included in the Usual Care
(UC) group.
Because of the nature of the intervention, neither the
patients nor the physicians were blinded to the patient’s
group assignment. However outcome assessors and data
analysts were blinded.
Procedures
All the patients were submitted to a cardiology office
visit at baseline (T0) and at the end of the study (T1).
During these visits, BP measurements were done always
using the same oscillometric device following published
guidelines [21]. The device measured the BP three times
at intervals and the mean of three values was recorded
as the BP for that visit. If needed, current therapy was
changed or new antihypertensive drugs were started.
At T1, patients performed an ABPM using a validated
Mobil O Graph (I.E.M. GMBH, Stolberg, DE) to confirm
the documented BP values recorded at this visit. The dur-
ation of home follow-up was spread over a minimum of
40 days to a maximum of 120 days. The variability was re-
lated to the time required to reach the target value of BP.
The BP monitoring was ended after at least 10 days of
stable BP target values.
HBT group
The service consisted of a structured physician-directed,
nurse-managed telephone support added to a BP tele-
monitoring. The staff included hypertension specialists,
cardiologists and trained nurses.
The structured telephone support has been described
in previous publications [20,22]. In brief our approach
included the following:
– Scheduled telephone appointments: these were done
approximately every 15 days. During these contacts,
the nurse carried out a standardized interview on
general clinical condition of the patients. The
patient was also counseled on weight management
and physical activity, smoking cessation, dietary
changes and stress management.
The patients were asked information about their
prescribed drugs and whether they took them
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offered strategies to improve patient’s compliance.
– Unscheduled appointments: these were initiated by
the patient when they experienced signs and
symptoms or had questions about their therapy. The
patient had the opportunity to contact the nurse at
any time of the day through the service centre and
report any clinical problems.
Both during scheduled and unscheduled telephone ap-
pointments the nurse relayed relevant information to
the clinical specialist and based on the available informa-
tion the specialist provided feedback or modified the pa-
tient’s therapy if found necessary. European guidelines
[21] were followed to titrate hypertensive drug with the
aim to reach BP controlled values.
Patients in this group were supplied with a blood pres-
sure measuring device (model A&D UA-767 Plus BT) and
a mobile phone which had a Java 2 Platform Micro Edition
(J2ME) application installed. The A&D sensor could trans-
mit the BP values to a mobile through Bluetooth connec-
tion and it could send them to a server via secure data
connection. At the beginning of the study an educational
meeting was held where the nurse explained the study to
the patients and taught them the correct way to use the
home BP instruments and the mobile phone and the cor-
rect way to measure BP based on the published guidelines
[21]. Figure 1 shows a summary diagram of the system.
The nurse, by entering the appropriate passwords
within the web platform, could retrieve, under the “per-
sonal health record” of the patient, the BP values which
were automatically updated with out-of-range values
highlighted. In case of abnormal readings, the nurse could
contact the patient through a service centre. The nurseFigure 1 Summary diagram of the home-based blood pressure telemcould also verify that the patient measured their BP with
the agreed frequency. In case of no measurement for at
least three days, the nurse contacted the patient.
UC group
In this group the patients were followed by their GPs
without any structured program.
Procedure to evaluate costs of HBT service
The costs were evaluated as follows:
1. Fixed costs included device rentals, equipment
purchases plus installation, installation of
telecommunication lines, monthly line charges, and
maintenance costs;
2. Variable costs included expenses for service centre
services, nurse-tutors, second opinions and
telecommunication.
The average annual salaries for nurse and specialist
were obtained and were used to compute the total cost
of health service staff, which included costs for duration
of consultations and costs for the extra-head activity
such as time for enrolment, discharge, web chart use,
and administrative activities. The service center costs in-
cluded the license for using the web platform to carry
on the service including the patient’s personal health
record, the call center calls and the general costs as ser-
vice etc.…
Statistics
The analysis was carried out with Graph Pad Prism 4
version 4.03 and MedCalc version 11.4.2. Statistical sig-
nificance was assessed by using a paired t-test for twoonitoring system. BP indicates blood pressure.
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tion of the two treatment arms and 2-way ANOVA per-
formed within-subject factors (SBP and DBP at T0 and
T1 between groups). The χ-square analysis and analysis
by Fisher’s exact test was carried out. A p-value <0.05
was considered statistically significant. Data are repre-
sented as mean ± standard deviation (SD) and as mean ±
95% Confidence Interval.Results
Patient population
Figure 2 shows participants flow throughout the study.
From 2155 patients screened, 210 patients (10%) had met
inclusion criteria. 37 patients were excluded. 74 patients
(38 males and 36 females) were enrolled in the HBT group
and 94 patients (49 males and 45 females) in the UC
group.Figure 2 Participants flow. HBT, indicates home-based telemedicine; UC,Table 1 shows the characteristics of the patient
population at baseline (T0). No significant differ-
ences in the main parameters were found between
the two groups.
Telemedicine service
During the period (80 ± 25 days), 17401 BP measure-
ments were taken (236 ± 136/patient) corresponding to a
mean daily measurement of 3 ± 1.7. The average number
of BP measurements per day was 5.6 ± 2.5 during the
first week and 4.3 ± 3.8 measurements/day during the
last week of the study.
The telephone contacts initiated by the nurse during
the study equaled to 5.2 ± 4.3/patient (370 in total). All
actions were focused on educational reinforcements and
therapeutic compliance verifications. The changes in
drug therapy suggested during the telephone contacts
were 1.81 ± 1.73 per patient.indicates usual care.
Table 1 Characteristics of the two patient populations at baseline (T0)
Patients HBT group UC group P=
n = 74 n = 94
M/F (%) 38/36 (51/49%) 50/44 (53/47%) 0.77
mean age ± SD (years) 59.7 ± 12.5 59.1 ± 13.3 0.76
Mean follow-up (days) 80 ± 25 82 ± 28 0.54
Pts followed for 40–65 days 21 29
Pts followed for 66–99 days 38 33
Pts followed for 100–120 days 10 25
Pts followed for 120–130 days 5 7
Diagnosis:
Hypertension (H) 74 (100%) 94 (100%)
H + hypertensive cardiomyopathy 10 (14%) 9 (10%)
H + ischemic cardiomyopathy 1 (1.4%) 2 (2%)
BMI 27 ± 6 28 ± 5.2 0.25
Risk factors (%): 0.45
Diabetes 12 (16%) 18 (19%)
Obesity 21 (28%) 30 (32%)
Family History 66 (89%) 77 (82%)
Dyslipidemia 20 (27%) 29 (31%)
Smokers 12 (16%) 10 (11%)
Ex-smokers 13 (18%) 8 (9%)
Patients with >2 risks 43 (58%) 50 (53%)
BMI indicates body mass index; HBT, indicates home-based telemedicine; UC, indicates usual care; SD, standard deviation.
Bernocchi et al. BMC Medical Informatics and Decision Making 2014, 14:52 Page 5 of 8
http://www.biomedcentral.com/1472-6947/14/52The contacts initiated by the patients were 0.4 ± 0.9/
patient (30 in total).
Table 2 shows the data relevant to the home telemedi-
cine intervention.
BP measurements
Figure 3 shows SBP and DBP changes in the two groups.
No significant differences in BP values were observed be-
tween the two groups at baseline (T0). In the UC group,
at the end of the study period, the mean SBP values de-
creased from 156 ± 16 mmHg to 149 ± 17 mmHg (−6.8 ±
14.6, p < 0.05) and mean DBP values from 90 ± 8 mmHg
to 86 ± 9 mmHg (−4 ± 8, p < 0.05).
In the HBT group, the mean SBP values decreased from
153 ± 19 mmHg to 130 ± 15 mmHg (−22.3 ± 22.6 mmHg,
p < 0.0001) and DBP values decreased from 89 ± 10 mmHg
to 76 ± 11 mmHg (−13 ± 12,2 mmHg, p < 0.0001). The
ABPM values, at the end of the study (T1) were as follows:
SBP was 136 ± 11 mmHg in the UC group and 125 ±
11 mmHg in the HBT group; DBP was 81 ± 9 mmHg in
the UC group and 76 ± 8 mmHg in the HBT group.
BP values measured at the office at final visit in the UC
group vs. the values measured at the baseline showed poor
BP control with 81% of patients with out-of-range SBP
values and 62% of patients with out-of-range DBP values.
On the contrary, in HBT group the percentage of patientswith out-of-range values at the final visit were 26% for
SBP and 8% for DBP.
The 2-way ANOVA performed on BP values of UC
group vs. HBT Group confirmed the better BP control
in the HBP group for both SBP and DBP (p < 0.001).
Drugs used during the study
The analysis by Fisher’s exact test carried out between treat-
ment groups at T0 and T1 showed a significant increase in
the use of Angiotensin Converting Enzyme -inhibitor and/
or Angiotensin II antagonists (p = 0.001), diuretic (p < 0.05)
in patients in the HBT group compared with the UC group.
The use of α-adrenergic drugs in HBT group was increased
but the increase was not statistically significant.
At the final visit, the mean number of drugs prescribed
per patient was greater in the HBT group (2.5 ± 1.1 drugs/
patient, with T1 vs. T0 p <0.0001) compared with the UC
group (2.0 ± 1.1 drugs/patient, with non-significant T1 vs.
T0). In fact, we observed that in the UC group only 23%
of patients had their drug regimen changed compared to
70% in the HBT group.
Cost was calculated as follows
i) Rental of BP device (A&D UA-767BT) and mobile
phone software and data connection = 76 €/patient
Table 2 Structured telephone support
Scheduled contacts per patient (total) 5.2 ± 4.3 (370)
Reasons for scheduled contacts:
- scheduled control 148
- BP values above the threshold 176
- BP values below the threshold 11
- data not sent 35
Actions undertaken during scheduled contacts:
- educational reinforcements., therapeutic compliance verifications, rescheduled contacts, etc.… 370
- therapeutic changes 124
- contacts with cardiologist 8
- contacts with other specialists 2
- requests for diagnostic examinations 7
- sending to the emergency room for syncope 1
Unscheduled contacts per patient (total) 0.4 ± 0.9 (30)
Reasons for unscheduled contacts:
- communications 5
- BP values above the threshold 18
- BP values below the threshold 4
- comfort request for anxiety 3
Actions undertaken:
- educational reinforcements., therapeutic compliance verifications, rescheduled contacts 27
- therapeutic changes 10
- contacts with cardiologist 2
- contacts with GP 1
BP indicates blood pressure; GP, general practitioner.
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iii)Reimbursement for nurse-tutor = 45 €/patient
iv) Physician specialist costs = 15 €/patient [specialist’s
intervention only during telemedicine, more or less
10 minute for patient].
Total costs = 166 €/patient (2.1 €/patient/day)Figure 3 Variation of systolic BP and diastolic BP of the two groups o
pressure, HBT, indicates home-based telemedicine, UC, indicates usual careDiscussion
The results obtained by this telemedicine approach in
patients with poor control of hypertension would seem
to confirm the importance of a much higher level of com-
pliance with respect to regular BP measurement, drug
compliance and therapy adjustments [23,24]. Technology
alone will likely fail to increase patient’s self-managementf patients measured during the study period. BP indicates blood
***p < 0.0001 within group.
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with out-of-range BP may benefit from more intensive
intervention that can be provided by nurses in a struc-
tured model connected with physicians.
In comparison with the previous studies, the educa-
tional program run by the nurses is fundamental; the
physicians are immediately made aware when BP values
are outside the range. This leads to re-evaluation of drug
compliance or drug therapy. Moreover, when the pa-
tients realize that their adherence is constantly and care-
fully checked, they acquire a feeling of greater control
and consequently higher compliance which contributes
to positive effects that can be observed in the first few
weeks.
Through telemedicine, symptoms of hypertension or
hypotension, malaise, or requests for comfort or simple
communications needs can be relayed in real time lead-
ing to greater patient satisfaction. Moreover, the con-
tinuous monitoring of patients followed by appropriate
intervention is a critical attribute of the program. This is
probably the reason why in the HBT group there was a
higher number of patients (70%) in whom the drug ther-
apy was modified compared to those in the UC group
(23%). The complete optimization of the treatment
probably requires a longer period with more frequent
nurse-patient contacts. In this respect, telemedicine
could be an excellent addition which could reduce the
number of office visits [12].
It is true that in both groups, at final visit, both SBP
and DBP were significantly lower but only in the HBT
group there was a clinically relevant BP reduction, with
values overlapping the BP levels which are recognized as
the target according to International Guidelines [21].
A number of meta-analysis studies have shown that a
BP monitoring, compared to a single office visit meas-
urement, has the potential to better manage uncon-
trolled hypertension [9,14-17].
We have obtained positive results thanks to the use of
a well-organized telemedicine program in which nursing
and specialist medical staff play an important role
[8,22,25]. Another important factor was that the tech-
nique was easy to use and was reliable with no major
complaints from the patients.
BP is usually sub-optimally controlled due to various
factors including the fact that it is often asymptomatic,
requires continuous treatment for life, with drug related
side effects leading to poor drug compliance [26-28].
The importance of self BP measurement is an educa-
tional goal for the patient. This goal cannot be achieved
by a single office visit. Furthermore, because of the is-
sues with cost containment, repeated office visits are dis-
couraged. In addition, the Telemedicine approach which
combines nurse support plus remote monitoring, re-
duces the problem of “white coat syndrome” [29]. Aneffective monitoring program for a period of 2–4 months
associated with a structured physician-nurse approach can
lead to beneficial overall effect for patients with uncon-
trolled hypertension.
Telemedicine services provide an additional value to
standard of care with only a small cost addition. In view
of the results obtained (greater significant reduction in
the HBT group vs. the SC group), it would be crucial to
plan randomized studies with a longer home follow-up
to confirm these findings and to verify the efficacy of
Telemedicine intervention in the reduction of acute car-
diovascular events, which are known to increase by 30%
for every 10 mmHg increase in BP [21].
Limitation of the study
One limitation of the study is that it was carried out fol-
lowing a non-randomized design.
Another limitation is the lack of baseline ABPM since
the study was conducted in the real clinical practice
where ABPM is not always performed.
The cost analysis considers only the services provided
to the patient in the HBT group and does not evaluate
the cost effectiveness of the service.
Conclusions
This study indicates that a telemedicine service, consisting
of structured physician-directed, nurse-managed tele-
phone support added to remote telemonitoring is feasible,
reliable and has a positive effect on blood pressure con-
trol. This type of approach could decrease the number of
hypertensive patients that are currently being treated but
who are still uncontrolled.
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